Sevoflurane, USP (Inhalation Anesthetic)
Recall D-1262-2014, part of FDA recall event 68004. See Piramal Critical Care, Inc.'s company page.
Piramal Critical Care, Inc. started this Class II drug recall on Apr 7, 2014 (voluntary: firm initiated); FDA lists it as terminated, terminated Dec 15, 2014.
- Classification: Class II
- Started: Apr 7, 2014
- Status: Terminated
Failed pH Specifications: product was too acidic.
- Product
- Sevoflurane, USP (Inhalation Anesthetic), Rx Only, 250 mL Amber Bottle. Manufactured By: Piramal Critical Care, 3950 Schelden Circle, Bethlehem, PA 18017. NDC: 66794-015-25.
- Quantity
- 12,600 bottles
- Lots and codes
- Lot #: S2611I28 (exp 9/16), S2511I14 (exp 9/16), S2531I16 (exp 9/16), S2721J21 (exp 10/16), S2871K03 (exp 11/16), S2881K03 (exp 11/16), and S2931K07 (exp 11/16).
- Distribution
- To wholesale distributors and retailers located Nationwide.
- Recalling firm
- Piramal Critical Care, Inc., Bethlehem, PA, United States
- How the firm notified
- Letter
- FDA classified
- Apr 25, 2014
Newest first, one product per recall event; search them all
- Rocuronium Bromide Injection 50mg/5 mL, 5mL Multi-Dose Vial, Rx only, Manufactured for: Piramal Critical Care,…D-0019-2022 · Class II · Sep 10, 2021 · Terminated
- Gablofen (baclofen injection), 50 mcg/mL, Single Use Syringe, Rx only, packaged in a box containing one 1 mL syringe,…D-1742-2019 · Class II · Jul 8, 2019 · Terminated
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports